companiesSEC EDGAR
BridgeBio Oncology Therapeutics, Inc.
SEC EDGAR published this disclosure on 2026-08-12. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001193125-26-345123
cik1869105
company nameBridgeBio Oncology Therapeutics, Inc.
form424B3